Related Experiment Videos

Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan

Jiann-Shing Jeng1, Wei-Hsian Yin2, Chin-Chou Huang3

  • 1Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|November 27, 2013
PubMed

Insights

Achieving lipid and blood pressure targets in Taiwanese patients with cardiovascular diseases remains suboptimal, especially for those with cerebrovascular disease and women. Enhanced efforts are needed to meet guideline recommendations for secondary prevention.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVD) and coronary artery disease (CAD) necessitate aggressive risk factor management to prevent secondary comorbidities.
  • Guideline recommendations exist for lipid and blood pressure (BP) control in these high-risk patients.

Purpose of the Study:

  • To evaluate the adherence to guideline-recommended lipid and BP control targets in patients with established CVD, CAD, or both in Taiwan.

Main Methods:

  • A multicenter cohort study involving 3316 outpatients with CVD and/or CAD across 14 hospitals in Taiwan.
  • Comparison of risk factors (lipids, BP, diabetes) and medication use between patient groups.
  • Analysis of achievement rates for lipid and BP control targets.

Main Results:

  • Only 54.8% and 55.9% of patients achieved recommended lipid and BP targets, respectively.
  • Patients with cerebrovascular disease (CVD) were older, had higher hypertension rates, and were less likely to achieve targets (aOR 0.61).
  • Women were also less likely to achieve recommended lipid and BP targets (aOR 0.65).

Conclusions:

  • Guideline-recommended lipid and BP control targets are suboptimal in Taiwanese patients with CAD and CVD.
  • Target achievement requires greater clinical focus, particularly for patients with CVD and for women.
Abstract

Keywords:
adherencecerebrovascular diseasecoronary artery diseasehypertensionlipids

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891